Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Medulloblastoma × Doxorubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 103 Lymphoma 67 Lymphoma, Large B-Cell, Diffuse 48 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Sarcoma 33 Lymphoma, Non-Hodgkin 29 Hodgkin Disease 27 Leukemia 23 Burkitt Lymphoma 22 Neoplasms 19 Lymphoma, Mantle-Cell 18 Triple Negative Breast Neoplasms 15 Multiple Myeloma 15 Lymphoma, Follicular 15 Lymphoma, B-Cell 14 Lymphoma, Large-Cell, Anaplastic 12 Carcinoma, Hepatocellular 12 Breast Neoplasms, Male 11 Neuroblastoma 10 Recurrence 9 Ovarian Neoplasms 9 Neoplasm Metastasis 9 Inflammatory Breast Neoplasms 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, T-Cell, Peripheral 8 Lymphoma, T-Cell 8 Osteosarcoma 7 Fallopian Tube Neoplasms 7 Urinary Bladder Neoplasms 6 Liposarcoma 6

Interventions

Vincristine 8 Magnetic Resonance Spectroscopy 8 Cyclophosphamide 7 Cisplatin 6 X-Rays 5 Specimen Handling 5 Radiotherapy 5 Phantoms, Imaging 5 Irinotecan 5 Carboplatin 5 Temozolomide 4 Radiation 4 Platinum 4 Nuclear Medicine Department, Hospital 4 Lomustine 4 palbociclib 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Etoposide 3 Biopsy 3 1,2-diaminocyclohexaneplatinum II citrate 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 sonidegib 2 selpercatinib 2 olaparib 2 merphos 2 larotrectinib 2 ivosidenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡